文献速递流行病学与生物统计临床试验与 GCP

贝叶斯响应自适应随机化在整群随机对照试验中的应用

Bayesian Response-Adaptive Randomization for Cluster Randomized Controlled Trials.
PubMed 文献 · Stat Med · 2026-01-01

针对整群随机对照试验中平衡随机化可能带来的物流挑战和资源压力,提出基于汤普森抽样的贝叶斯响应自适应随机化设计,利用中期后验分布动态分配整群至最有效治疗臂,并纳入基于预设后验概率阈值的早期疗效与无效停止规则。模拟研究表明该设计在维持稳健统计功效和控制假阳性率的同时,优先将更多整群分配给更有效的干预,在伦理和效率方面均有改善。

要点

  • 提出基于汤普森抽样的贝叶斯响应自适应随机化设计用于整群随机对照试验。
  • 设计利用中期后验分布动态分配整群至最有效治疗臂,并纳入早期停止规则。
  • 模拟研究显示该设计在维持统计功效和控制假阳性率的同时优先分配更多整群至更有效干预。

核心结论

  • 基于汤普森抽样的贝叶斯响应自适应随机化设计在整群随机对照试验中相比标准平行两臂设计在伦理和效率方面均有改善。

研究设计与样本

  • 提出贝叶斯响应自适应随机化设计,基于汤普森抽样,利用马尔可夫链蒙特卡洛抽样根据治疗效应的中期后验分布动态分配整群至最有效治疗臂。
  • 设计纳入基于预设后验概率阈值的早期疗效与无效停止规则。
  • 通过模拟研究评估设计在不同组内相关系数、整群大小和效应量下的操作特性,并与标准平行两臂整群随机对照临床试验设计进行比较。
  • 模拟研究基于一项HIV行为试验。

主要发现

  • 模拟研究表明该设计优先将更多整群分配给更有效的干预,同时维持稳健的统计功效并控制假阳性率。
  • 与标准平行两臂整群随机对照临床试验设计相比,该设计在伦理考虑和效率方面均有改善。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cluster randomized controlled trials where groups (or clusters) of individuals, rather than single individuals, are randomized are especially useful when individual-level randomization is not feasible or when interventions are naturally delivered at the group level. Balanced randomization in the cluster randomized trial setting can pose logistical challenges and strain resources if subjects are randomized to a non-optimal arm. We propose a Bayesian response-adaptive randomization design for cluster randomized controlled trials based on Thompson sampling, which dynamically allocates clusters to the most efficacious treatment arm based on the interim posterior distributions of treatment effects using Markov chain Monte Carlo sampling. Our design also incorporates early stopping rules for efficacy and futility determined by prespecified posterior probability thresholds. The performance of the proposed design is evaluated across various operating characteristics under multiple settings, including varying intra-cluster correlation coefficients, cluster sizes, and effect sizes. Our adaptive approach is also compared with a standard, parallel two-arm cluster randomized controlled clinical trial design, highlighting improvements in both ethical considerations and efficiency. From our simulation studies based on an HIV behavioral trial, we demonstrate these improvements by preferentially assigning more clusters to the more efficacious intervention while maintaining robust statistical power and controlling false positive rates.

来源:Stat Med,查看原文。版权归原作者所有。

引用

  1. Liu Y, Young Karris M, Jain S, et al. Bayesian Response-Adaptive Randomization for Cluster Randomized Controlled Trials. Stat Med. 2026. PMID: 41567115. doi:10.1002/sim.70386

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。